Literature DB >> 23649932

Surgery for the intact primary and stage IV breast cancer…lacking "robust evidence".

Seema A Khan.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23649932     DOI： 10.1245/s10434-013-3002-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.

Authors:  Kehan Song; Jian Song; Kaiyuan Lin; Feiyan Chen; Xiaosheng Ma; Jianyuan Jiang; Feng Li
Journal:  Int Orthop       Date:  2019-05-24       Impact factor: 3.075

Review 2.  Oligometastatic breast cancer: a shift from palliative to potentially curative treatment?

Authors:  Simona Di Lascio; Olivia Pagani
Journal:  Breast Care (Basel)       Date:  2014-02       Impact factor: 2.860

Review 3.  Resection of the primary tumor in stage IV breast cancer.

Authors:  Tadahiko Shien; Hiroyoshi Doihara
Journal:  World J Clin Oncol       Date:  2014-05-10

4.  The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis.

Authors:  San-Gang Wu; Wen-Weng Zhang; Jia-Yuan Sun; Feng-Yan Li; Huan-Xin Lin; Juan Zhou; Zhen-Yu He
Journal:  Oncotarget       Date:  2017-06-29

5.  Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study.

Authors:  Dongxiao Zhang; Yinjun Dong; Xiubin Sun; Shuanghu Yuan; Jinming Yu
Journal:  Cancer Manag Res       Date:  2018-12-27       Impact factor: 3.989

6.  Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).

Authors:  Sara Lopez-Tarruella; M J Escudero; Marina Pollan; Miguel Martín; Carlos Jara; Begoña Bermejo; Angel Guerrero-Zotano; José García-Saenz; Ana Santaballa; Emilio Alba; Raquel Andrés; Purificación Martínez; Lourdes Calvo; Antonio Fernández; Norberto Batista; Antonio Llombart-Cussac; Antonio Antón; Ainhara Lahuerta; Juan de la Haba; José Manuel López-Vega; E Carrasco
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.